SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: Steve Harmon who wrote (1774)12/3/1998 7:17:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Excuse me that would have been the profit made in 2 years made on the IMNX stock.

Actually Cistron would now be holding $157 million in IMNX stock which would equate to roughly $7 a share on CIST's balance sheet...

Instead Cistron shareholders received $21 million in cash from IMNX which is currently worth $6 million!